Andrea Pietrobattista
Overview
Explore the profile of Andrea Pietrobattista including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safarikia S, Cirelli R, Spagnoletti G, Martinelli D, Bravetti G, Francalanci P, et al.
J Inherit Metab Dis
. 2025 Mar;
48(2):e70010.
PMID: 40026238
The human liver plays a central metabolic role; however, its physiology may become imbalanced in inborn errors of metabolism (IEM), a broad category of monogenic disorders. Liver transplantation has been...
2.
Veraldi S, Della Volpe L, Cecinati V, Francalanci P, Maggiore G, Pietrobattista A
Gastroenterol Rep (Oxf)
. 2025 Feb;
13:goaf014.
PMID: 39925942
No abstract available.
3.
Siri B, Greco B, Martinelli D, Cairoli S, Guarnera A, Longo D, et al.
J Inherit Metab Dis
. 2025 Jan;
48(1):e12843.
PMID: 39776112
Liver transplantation (LTx) is increasingly used in Urea Cycle Defects (UCDs) to prevent recurrent hyperammonemia and related neurological irreversible injury. Among UCDs, argininosuccinate lyase deficiency (ASLD) has a more complex...
4.
Lefere S, Mosca A, Hudert C, Dupont E, Fitzpatrick E, Kyrana E, et al.
Hepatology
. 2024 Sep;
PMID: 39235883
No abstract available.
5.
Lefere S, Mosca A, Hudert C, Dupont E, Fitzpatrick E, Kyrana E, et al.
Hepatology
. 2024 Aug;
PMID: 39190698
No abstract available.
6.
Lefere S, Mosca A, Hudert C, Dupont E, Fitzpatrick E, Kyrana E, et al.
Hepatology
. 2024 Jul;
PMID: 39028885
Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent pediatric liver disease, yet accurate risk scores for referral of children/adolescents with suspected clinically significant liver fibrosis...
7.
Di Maio V, Gentile L, Scutari R, Colagrossi L, Coltella L, Ranno S, et al.
Microorganisms
. 2024 Apr;
12(4).
PMID: 38674772
This study described 17 cases of children admitted to the Bambino Gesù Children's Hospital with acute hepatitis of unknown origin between mid-April and November 2022. Following the World Health Organization's...
8.
Antonella M, Pietrobattista A, Maggiore G
Pediatr Rep
. 2024 Apr;
16(2):288-299.
PMID: 38651464
The term "non-alcoholic fatty liver disease" (NAFLD) has been, for a long time, used to describe the spectrum of liver lesions encompassing steatosis, steatohepatitis (NASH), and steatotic cirrhosis [...].
9.
Beati F, Mosca A, Pietrobattista A, Liccardo D, Ronci S, Monti L, et al.
Front Surg
. 2024 Mar;
11:1353424.
PMID: 38496210
Introduction: The diagnosis of biliary atresia (BA) remains challenging, and there is still uncertainty regarding the optimal time to perform a Kasai portoenterostomy (KPE). Little is known about the difficulties...
10.
Francalanci P, Giovannoni I, Tancredi C, Gagliardi M, Palmieri R, Brancaccio G, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254797
Purpose: Univentricular heart is corrected with the Fontan procedure (FP). In the long term, so-called Fontan-associated liver diseases (FALDs) can develop. The aim of this study is to analyze the...